153
Views
37
CrossRef citations to date
0
Altmetric
Case Study

Selegiline in the management of apathy following traumatic brain injury

&
Pages 149-154 | Received 20 Jun 2003, Accepted 29 Apr 2004, Published online: 03 Jul 2009

References

  • Teasdale G, Mendelow D. Pathophysiology of head injuries. In: Brooks N, editor. Closed Head Injury. Psychological, Social and Family Consequences. Oxford: Oxford University Press; 1984. pp 5–36.
  • Thornhill S, Teasdale GM, Murray GD, et al. Disability in young people and adults one year after head injury: Prospective cohort study. British Medical Journal 2000;320:1631–5.
  • Mann RS. Differential diagnosis and classification of apathy. American Journal of Psychiatry 1990;147:22–30.
  • Mann RS. Apathy: A neuropsychiatric syndrome. Journal of Neuropsychiatry & Clinical Neuroscience 1991;3:243–54.
  • Mann RS, Firinciogullari S, Biedrzycki RC. The source of convergence between measures of apathy and depression. Journal of Affective Diseases 1993;28:117–24.
  • Mann RS, Firinciogullari S, Biedrzycki RC. Group differ-ences in the relationship between apathy and depression. Journal of Nervous Mental Diseases 1994;182:235–9.
  • Stuss DT, van Reekum R, Murphy KJ. Diferentiation of states and causes of apathy. In: Borod J, editor. Neuropsychology of Emotion. New York: Oxford University Press; 2000, pp 340–63.
  • Mann RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Reseasrch 1991;38:143–62.
  • Kant R, Duffy JD, Pivovamil A. Prevalence of apathy following head injury. Brain Injury, 1998;12:87–92.
  • Mega MS, Cummings JL. Frontal cortical-subcortical circuits and neuropsychiatric disorder. Journal of Neuropsychiatry & Clinical Neuroscience 1994;6:358–70.
  • Mann RS, Fogel BS, Hawkins J, et al. Apathy: A treatable syndrome. Journal of Neuropsychiatry & Clinical Neuroscience 1995;7:23–30.
  • Kraus ME. Neuropsychiatric sequelae of stroke and traumatic brain injury: The role of psychostimulants. International Journal of Psychiatry Medicine 1995;25:39–51.
  • Watanabe MD, Martin EM, Deleon OA, et al. Successful methylphenidate treatment of apathy after subcortical infarcts. Journal of Neuropsychiatry & Clinical Neuroscience 1995;7:502–4.
  • Galynker I, Ieronimo C, Miner C, et al. Methylphenidate treatment of negative symptoms in patients with dementia. Journal of Neuropsychiatry & Clinical Neuroscience 1997;9:231–9.
  • Glenn MB. Methylphenidate for cognitive and behavioural dysfunction after traumatic brain injury. Journal of Head Trauma Rehabilitation 1998;13:87–90.
  • Plutchik L, Snyder S, Drooker M, et al. Methylphenidate in post liver transplant patients. Psychosomatics 1998; 39:118–23.
  • Nickels JL, Schneider WN, Dombovy ML, et al. Clinical use of amantadine in brain injury rehabilitation. Brain Injury 1994;8:709–18.
  • van Reekum R, Bayley M, Garner S, et al. N of 1 study: Amantadine for the arnotivational syndrome in a patient with traumatic brain injury. Brain Injury 1995;9:49–53.
  • Zafonte RD, Watanabe T, Mann NR. Amantadine: A potential treatment for the minimally conscious state. Brain Injury 1998;12:617–21.
  • Shiller AD, Burke DT, Kim HJ, et al. Treatment with amantadine potentiated motor learning in a patient with traumatic brain injury of 15 years duration. Brain Injury 1999;13:715–21.
  • Kraus ME, Maki P. The combined use of amantadine and l-dopa/carbidopa in the treatment of chronic brain injury. Brain Injury 1997;11:455–60.
  • Karli DC, Burke DT, Kim HJ, et al. Effects of dopaminergic combination therapy for frontal lobe dysfunction in traumatic brain injury. Brain Injury 1999;13:63–8.
  • Whyte J, Vaccaro M, Grieb-Neff P, et al. Psychostimulant use in the rehabilitation of individuals with traumatic brain injury. Journal of Head Trauma Rehabilitation 2002;17:284–99.
  • Meythaler JM, Brunner RC, Johnson A, et al. Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: A pilot double-blind random-ized trial. Journal of Head Trauma Rehabilitation 2002;17:300–13.
  • McDowell S, Whyte J, D'Esposito M. Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 1998;121:1155–64.
  • Gualtieri CT. Psychostimulants, dopamine agonists and amantadine. In: Brain Injury and Mental Retardation. Philadelphia: Lippincott Williams & Wilkins; 2002. pp 301–22.
  • Schaller JL, Behar D. Selegiline for the delivery of small doses of amphetamine. Journal of Neuropsychiatry & Clinical Neuroscience 1997;9:301-2.28. Zhu J, Hamm RJ, Reeves TM, et al. Post injury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Experimental Neurology 2000;166: 136–52.
  • American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington DC: American Psychiatric Association; 2000.
  • Varney NR, Martzke JS, Roberts RJ. Major depression in patients with closed head injury. Neuropsychology 1987; 1:7–9.
  • Jorge RE, Robinson RG, Arndt SV, et al. Depression and traumatic brain injury: A longitudinal study. Journal of Affective Disorders 1993;27:233–43.
  • Kreutzer JS, Seel RT, Gourley E. The prevalence and symptom rates of depression after traumatic brain injury: A comprehensive examination. Brain Injury 2001;15:563–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.